3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
13
Sarcoma
6
Genitourinary
4
Gastrointestinal
4
Thoracic
1
Other
1
Lymphoid
1
Head & Neck
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Melanoma
467
Skin Neoplasms
144
Carcinoma, Basal Cell
94
Breast Neoplasms
78
Neoplasms
68
Lymphoma, T-Cell, Cutaneous
62
Lung Neoplasms
57
Carcinoma, Squamous Cell
40
Carcinoma, Non-Small-Cell Lung
40
Mycosis Fungoides
39
Uveal Melanoma
38
Sezary Syndrome
37
Lymphoma, Non-Hodgkin
35
Lymphoma
35
Keratosis, Actinic
35
Pancreatic Neoplasms
34
Sarcoma
33
Prostatic Neoplasms
33
Head and Neck Neoplasms
33
Colorectal Neoplasms
33
Leukemia, Lymphocytic, Chronic, B-Cell
31
Ovarian Neoplasms
30
Urinary Bladder Neoplasms
29
Multiple Myeloma
29
Precursor Cell Lymphoblastic Leukemia-Lymphoma
28
Lymphoma, B-Cell, Marginal Zone
28
Colonic Neoplasms
28
Lymphoma, Mantle-Cell
27
Lymphoma, Follicular
27
Leukemia
27
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Leiomyoma
×
Dermatologic
×
Clear all
NCT06583395
2024-11-01
QUANTUM
VitaMed Research LLC
Enrolling by invitation
3,000 enrolled